Refractive errors among infants with retinopathy of prematurity who received intravitreal bevacizumab
Joint Authors
Khurays, Hibah Muhammad
Khatatibah, Ahmad Isa
al-Isa, Muhammad Id
al-Shudayfat, Muhammad Ali
al-Saa’ida, Muhammad Jalal
Harahishah, Hasan Wannas
Source
Journal of the Royal Medical Services
Issue
Vol. 29, Issue 1 (30 Apr. 2022), pp.56-61, 6 p.
Publisher
The Royal Medical Services Jordan Armed Forces
Publication Date
2022-04-30
Country of Publication
Jordan
No. of Pages
6
Main Subjects
Abstract EN
Aim : to explore the frequency and type of refractive error in eyes that received intravitreal bevacizumab injection for treatment of retinopathy of prematurity (ROP) and to compare the results with eyes which received intravitreal bevacizumab combined with laser photocoagulation.
methods : a prospective study conducted at the ophthalmology clinic of Queen Rania al Abdullah hospital for children between Jan.
2019 and Oct.
2019.
all premature infants who were diagnosed to have severe forms of retinopathy of prematurity and met the threshold to receive intravitreal bevacizumab alone (group a) or intravitreal bevacizumab combined with laser photocoagulation (group b).
all patients underwent refraction under cycloplegic effect and the axial length was measured using ultrasound as well.
in addition, birth weight, gestational age and result of refraction were recorded.
the results of the two groups were compared.
all data were analyzed and compared to that obtained in other studies conducted worldwide.
results : 41 patients (56 eyes) were enrolled in the study; 36 eyes received a single intravitreal bevacizumab of 0.625 mg and 20 eyes received intravitreal bevacizumab combined with laser photocoagulation of the peripheral retina.
the frequency of myopia and high myopia was 36% and 8% in group a and 75% and 40% in group b respectively.
the axial lengths of both groups were comparable.
conclusion : in patients with retinopathy of prematurity myopia and high myopia were significantly more frequent in eyes receiving combined intravitreal bevacizumab and laser photocoagulation than in eyes receiving intravitreal bevacizumab alone which was not related to the axial length.
American Psychological Association (APA)
Khurays, Hibah Muhammad& Khatatibah, Ahmad Isa& al-Isa, Muhammad Id& al-Shudayfat, Muhammad Ali& al-Saa’ida, Muhammad Jalal& Harahishah, Hasan Wannas. 2022. Refractive errors among infants with retinopathy of prematurity who received intravitreal bevacizumab. Journal of the Royal Medical Services،Vol. 29, no. 1, pp.56-61.
https://search.emarefa.net/detail/BIM-1435416
Modern Language Association (MLA)
Khurays, Hibah Muhammad…[et al.]. Refractive errors among infants with retinopathy of prematurity who received intravitreal bevacizumab. Journal of the Royal Medical Services Vol. 29, no. 1 (Apr. 2022), pp.56-61.
https://search.emarefa.net/detail/BIM-1435416
American Medical Association (AMA)
Khurays, Hibah Muhammad& Khatatibah, Ahmad Isa& al-Isa, Muhammad Id& al-Shudayfat, Muhammad Ali& al-Saa’ida, Muhammad Jalal& Harahishah, Hasan Wannas. Refractive errors among infants with retinopathy of prematurity who received intravitreal bevacizumab. Journal of the Royal Medical Services. 2022. Vol. 29, no. 1, pp.56-61.
https://search.emarefa.net/detail/BIM-1435416
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 60-61
Record ID
BIM-1435416